Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Vomiting 13Nausea 11Neoplasms 3Leukemia, Myeloid, Acute 2Carcinoma, Non-Small-Cell Lung 2Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Radiation Injuries 1Pruritus 1Postoperative Nausea and Vomiting 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Myelodysplastic Syndromes 1Multiple Myeloma 1Melanoma 1Lymphoma 1Lung Neoplasms 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1ITCH 1Hematologic Diseases 1Head and Neck Neoplasms 1Glioma 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Bile Duct Neoplasms 1

Interventions

Gemcitabine 20Fluorouracil 14Cisplatin 10Capecitabine 10Leucovorin 8durvalumab 6Oxaliplatin 6Erlotinib Hydrochloride 4Sorafenib 3Radiotherapy 3trifluridine tipiracil drug combination 2trametinib 2regorafenib 2pembrolizumab 2olaparib 2ceralasertib 2Specimen Handling 2Radiosurgery 2N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 2Magnetic Resonance Spectroscopy 2Lapatinib 2Irinotecan 2Filgrastim 2AZD 6244 2zimberelimab 1tremelimumab 1titanium silicide 1tislelizumab 1tegafur-gimeracil-oteracil 1seribantumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Bile Duct Neoplasms × Aprepitant × Clear all
NCT01534637 2018-08-15

Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy and Radiation Therapy for Pancreatic Cancer

Wake Forest University Health Sciences

Phase 2 Completed
22 enrolled 9 charts
Gastrointestinal

Bile Duct Neoplasms, Nausea, Pancreatic Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡